A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab
Public ClinicalTrials.gov record NCT04102007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Interventional, Open-label Study of Adult Subjects With Moderate to Severe Plaque Psoriasis Who Have a Suboptimal Response to Secukinumab or Ixekizumab and Are Switched to Risankizumab
Study identification
- NCT ID
- NCT04102007
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 244 participants
Conditions and interventions
Conditions
Interventions
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2019
- Primary completion
- Jan 16, 2022
- Completion
- Nov 6, 2022
- Last update posted
- Nov 26, 2023
2019 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance Dermatology and MOHs /ID# 216001 | Phoenix | Arizona | 85032 | — |
| Burke Pharmaceutical Research /ID# 225023 | Hot Springs | Arkansas | 71913-6404 | — |
| Arkansas Research Trials /ID# 225497 | North Little Rock | Arkansas | 72117 | — |
| Bakersfield Derma & Skin Cance /ID# 213480 | Bakersfield | California | 93309 | — |
| UC Davis Health /ID# 225367 | Sacramento | California | 95816-3300 | — |
| CCD Research, PLLC /ID# 216062 | Cromwell | Connecticut | 06416-1745 | — |
| Florida International Rsrch cr /ID# 224983 | Miami | Florida | 33173 | — |
| Advanced Medical Research /ID# 213484 | Sandy Springs | Georgia | 30328-6141 | — |
| Arlington Dermatology /ID# 216000 | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin, LLC /ID# 216004 | Indianapolis | Indiana | 46256 | — |
| DermAssociates-Rockville /ID# 213837 | Rockville | Maryland | 20850 | — |
| Cleaver Dermatology /ID# 226137 | Kirksville | Missouri | 63501-5362 | — |
| Central Dermatology, PC /ID# 213479 | St Louis | Missouri | 63117 | — |
| University Hospitals Case Medical Center /ID# 214795 | Cleveland | Ohio | 44106 | — |
| University of Pittsburgh MC /ID# 225644 | Pittsburgh | Pennsylvania | 15260 | — |
| Clinical Partners, LLC /ID# 213836 | Johnston | Rhode Island | 02919 | — |
| Arlington Research Center, Inc /ID# 215526 | Arlington | Texas | 76011 | — |
| Bellaire Dermatology /ID# 225486 | Bellaire | Texas | 77401 | — |
| Modern Research Associates, PL /ID# 213835 | Dallas | Texas | 75231 | — |
| Menter Dermatology Res Inst /ID# 214002 | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04102007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2023 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04102007 live on ClinicalTrials.gov.